Market Overview

UPDATE: Citigroup Raises PT on MedAssets from $15 to $16


Citigroup reiterated a Neutral rating on MedAssets (NASDAQ: MDAS) and raised its price target from $15 to $16.

Citigroup wrote, “We expect MDAS shares to be strong tomorrow and admit that we missed a recent opportunity to get more positive on the shares. We maintain our Neutral rating, and would look to get more positive should the shares come in or we find further upside to our estimates is possible. We are raising our target price to $16 from $15, reflecting 15x our revised 2012 EPS estimate.”

MedAssets closed at $12.85 on Wednesday.

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings


Related Articles (MDAS)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→